Files
Download Full Text (8.1 MB)
Contents
- Liposomal cisplatin analogue is less toxic and more effective than cisplatin
- Physicians can help allay fear by helping patients understand cancer risk
- The physician's role in smoking cessation
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
Publication Date
1993
Publisher
The University of Texas MD Anderson Cancer Center
City
Houston, Texas
Keywords
Khokhar, Abdul; Perez-Soler, Roman; Lopez-Berestein, Gabriel; Kondo, Al; Shallenberger, Rick; Cisplatin; Cisplatin -- analogs & derivatives; bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II); Organoplatinum Compounds; neodecanoic acid; Decanoic Acids; Oxaliplatin; Antineoplastic Agents; Smoking Cessation; Physician-Patient Relations; Tobacco Use Disorder; Risk Assessment; Risk Factors; Neoplasms.
Disciplines
History of Science, Technology, and Medicine | Oncology
Recommended Citation
Staff, "OncoLog, Volume 38, Number 03 July-September 1993" (1993). OncoLog MD Anderson's Report to Physicians (All issues). 47.
https://openworks.mdanderson.org/oncolog/47
Conditions Governing Access
Open
